Last reviewed · How we verify
PF-610,355
At a glance
| Generic name | PF-610,355 |
|---|---|
| Sponsor | Pfizer |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PF-610,355 CI brief — competitive landscape report
- PF-610,355 updates RSS · CI watch RSS
- Pfizer portfolio CI